The latest health and social care news and a look at research and development into the treatment of common and rare diseases alike. We also look at the vital changes being made to help deliver effective healthcare through the digital transformation within the NHS.
Adam Mence from L&R Medical UK explains how the company is empowering patients to manage their conditions while supporting NHS goals for improving care outcomes and efficiency. Overall, investing in self-care and innovative technologies is shown to be both clinically effective and cost-efficient.
The Council of European Dentists (CED) is a not-for-profit association representing over 340,000 dentists. Here, they address the relationship between oral health and overall health, as well as the necessary steps to improve access to dental care and reduce related inequalities.
Chronic pain can affect a person’s life in a myriad of ways. Asal Shirazi BEM, Founder of the Autoimmune Support & Awareness Foundation (ASA Foundation), talks us through some of the conditions associated with chronic pain and the advancements in pain management.
Kevin Ireson, the Sales Director at Mobile Rocket Ltd, explains how NHS 0-19 services and Family Hubs are being revolutionised through digital innovation.
Jakub Mazur, Deputy Mayor of Wrocław, Poland, and a member of ICLEI Europe’s Regional Executive Committee, discusses innovative food security policies, including how Wrocław is shaping a resilient future through food.
The opioid crisis has identified the extent of chronic pain as a health problem in Canada and the necessity of addressing pain as part of the solution to the crisis.
NHS trusts face numerous challenges that impact administrative efficiency and staff welfare. Peter Williams, CEO of SMS Tech, explains how the company’s solutions can streamline administrative burdens, reduce burnout, and support sustainability goals.
The report aims to help ICS leaders enhance collaboration between housing and health sectors across East England to address the root causes of poor health and improve overall community health outcomes.
Indigenous Peoples encounter numerous challenges in exercising their right to health. Lorna Rothery discussed the importance of collaborative and culturally sensitive approaches with Dr Sandra Del Pino, Advisor on Cultural Diversity at PAHO.
Recent Phase 3 trial results for icotrokinra (JNJ-2113), an investigational oral peptide from Johnson & Johnson, have shown the drug’s potential to offer significant relief for patients suffering from moderate-to-severe plaque psoriasis.
Abel Delgado, Managing Director of Tunstall Spain, explains the urgency of loneliness as a health problem for the elderly and what other regions can learn from Spain’s proactive and preventative approach, that benefits both physical and mental health.
